±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 445  |  »Ø¸´: 3
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

mengzhongmeng

[½»Á÷] Éú»¯Ãû´Ê½âÊÍ

ÉúÎﻯѧÃû´Ê½âÊÍ
µÚÒ»²¿·Ö
µÚÒ»ÕÂ
1,°±»ùËᣨamino acid£©:ÊǺ¬ÓÐÒ»¸ö¼îÐÔ°±»ùºÍÒ»¸öËáÐÔôÈ»ùµÄÓлú»¯ºÏÎ°±»ùÒ»°ãÁ¬ÔÚ¦Á-̼ÉÏ¡£
2£¬±ØÐè°±»ùËᣨessential amino acid£©:Ö¸ÈË£¨»òÆäËü¼¹×µ¶¯Î£¨Àµ°±ËᣬËÕ°±ËáµÈ£©×Ô¼º²»Äܺϳɣ¬ÐèÒª´ÓʳÎïÖлñµÃµÄ°±»ùËá¡£
3£¬·Ç±ØÐè°±»ùËᣨnonessential amino acid£©:Ö¸ÈË£¨»òÆäËü¼¹×µ¶¯Î×Ô¼ºÄÜÓɼòµ¥µÄǰÌåºÏ³É
²»ÐèÒª´ÓʳÎïÖлñµÃµÄ°±»ùËá¡£
4£¬µÈµçµã£¨pI,isoelectric point£©:ʹ·Ö×Ó´¦ÓÚ¼æÐÔ·Ö×Ó״̬£¬Ôڵ糡Öв»Ç¨ÒÆ£¨·Ö×ӵľ²µçºÉΪÁ㣩µÄpHÖµ¡£
5£¬ÜáÈýͪ·´Ó¦£¨ninhydrin reaction£©:ÔÚ¼ÓÈÈÌõ¼þÏ£¬°±»ùËá»òëÄÓëÜáÈýͪ·´Ó¦Éú³É×ÏÉ«£¨Ó븬°±Ëá·´Ó¦Éú³É»ÆÉ«£©»¯ºÏÎïµÄ·´Ó¦¡£
6£¬ëļü£¨peptide bond£©:Ò»¸ö°±»ùËáµÄôÈ»ùÓëÁíÒ»¸öµÄ°±»ùµÄ°±»ùËõºÏ£¬³ýÈ¥Ò»·Ö×ÓË®ÐγɵÄõ£°±¼ü¡£
7£¬ëÄ£¨peptide£©:Á½¸ö»òÁ½¸öÒÔÉϰ±»ùͨ¹ýëļü¹²¼ÛÁ¬½ÓÐγɵľۺÏÎï¡£
8£¬µ°°×ÖÊÒ»¼¶½á¹¹£¨primary structure£©:Ö¸µ°°×ÖÊÖй²¼ÛÁ¬½ÓµÄ°±»ùËá²Ð»ùµÄÅÅÁÐ˳Ðò¡£
9£¬²ãÎö£¨chromatography£©:°´ÕÕÔÚÒÆ¶¯ÏàºÍ¹Ì¶¨Ïà £¨¿ÉÒÔÊÇÆøÌå»òÒºÌ壩֮¼äµÄ·ÖÅä±ÈÀý½«»ìºÏ³É·Ö·Ö¿ªµÄ¼¼Êõ¡£
10£¬Àë×Ó½»»»²ãÎö£¨ion-exchange column£©Ê¹ÓôøÓй̶¨µÄ´øµç»ùÍŵľۺÏÊ÷Ö¬»òÄý½º²ãÎöÖù
11£¬Í¸Îö£¨dialysis£©:ͨ¹ýС·Ö×Ó¾­¹ý°ë͸ĤÀ©É¢µ½Ë®£¨»ò»º³åÒº£©µÄÔ­Àí£¬½«Ð¡·Ö×ÓÓëÉúÎï´ó·Ö×Ó·Ö¿ªµÄÒ»ÖÖ·ÖÀë´¿»¯¼¼Êõ¡£
12£¬Äý½º¹ýÂ˲ãÎö£¨gel filtration chromatography£©:Ò²½Ð×ö·Ö×ÓÅÅ×è²ãÎö¡£Ò»ÖÖÀûÓôø¿×Äý½ºÖé×÷»ùÖÊ£¬°´ÕÕ·Ö×Ó´óС·ÖÀëµ°°×ÖÊ»òÆäËü·Ö×Ó»ìºÏÎïµÄ²ãÎö¼¼Êõ¡£
13£¬Ç׺ϲãÎö£¨affinity chromatograph£©:ÀûÓù²¼ÛÁ¬½ÓÓÐÌØÒìÅäÌåµÄ²ãÎö½éÖÊ£¬·ÖÀëµ°°×ÖÊ»ìºÏÎïÖÐÄÜÌØÒì½áºÏÅäÌåµÄÄ¿µÄµ°°×ÖÊ»òÆäËü·Ö×ӵIJãÎö¼¼Êõ¡£
14£¬¸ßѹҺÏà²ãÎö£¨HPLC£©:ʹÓÿÅÁ£¼«Ï¸µÄ½éÖÊ£¬ÔÚ¸ßѹÏ·ÖÀëµ°°×ÖÊ»òÆäËû·Ö×Ó»ìºÏÎïµÄ²ãÎö¼¼Êõ¡£
15£¬Äý½ºµçÓ¾£¨gel electrophoresis£©:ÒÔÄý½ºÎª½éÖÊ£¬Ôڵ糡×÷ÓÃÏ·ÖÀëµ°°×ÖÊ»òºËËáµÄ·ÖÀë´¿»¯¼¼Êõ¡£
16£¬SDS-¾Û±ûÏ©õ£°±Äý½ºµçÓ¾£¨SDS-PAGE£©:ÔÚÈ¥ÎÛ¼ÁÊ®¶þÍé»ùÁòËáÄÆ´æÔÚϵľ۱ûÏ©õ£°±Äý½ºµçÓ¾¡£SDS-PAGEÖ»Êǰ´ÕÕ·Ö×ӵĴóС£¬¶ø²»ÊǸù¾Ý·Ö×ÓËù´øµÄµçºÉ´óС·ÖÀëµÄ¡£
17£¬µÈµç¾Û½ºµçÓ¾£¨IFE£©:ÀûÓÃÒ»ÖÖÌØÊâµÄ»º³åÒº£¨Á½ÐÔµç½âÖÊ£©ÔÚ¾Û±ûÏ©õ£°±Äý½ºÖÆÔìÒ»¸öpHÌݶȣ¬µçӾʱ£¬Ã¿ÖÖµ°°×ÖÊÇ¨ÒÆµ½ËüµÄµÈµçµã£¨pI£©´¦£¬¼´ÌݶÈ×ãµÄijһpHʱ£¬¾Í²»ÔÙ´øÓо»µÄÕý»ò¸ºµçºÉÁË¡£
18£¬Ë«ÏòµçÓ¾£¨two-dimensional electrophorese£©:µÈµç¾Û½ºµçÓ¾ºÍSDS-PAGEµÄ×éºÏ£¬¼´ÏȽøÐеȵç¾Û½ºµçÓ¾£¨°´ÕÕpI£©·ÖÀ룬ȻºóÔÙ½øÐÐSDS-PAGE£¨°´ÕÕ·Ö×Ó´óС·ÖÀ룩¡£¾­È¾É«µÃµ½µÄµçӾͼÊǶþά·Ö²¼µÄµ°°×ÖÊͼ¡£
19£¬Edman½µ½â£¨Edman degradation£©:´Ó¶àëÄÁ´ÓÎÀëµÄNÄ©¶Ë²â¶¨°±»ùËá²Ð»ùµÄÐòÁеĹý³Ì¡£NÄ©¶Ë°±»ùËá²Ð»ù±»±½ÒìÁòÇèËáõ¥ÐÞÊΣ¬È»ºó´Ó¶àëÄÁ´ÉÏÇÐÏÂÐÞÊεIJлù£¬ÔÙ¾­²ãÎö¼ø¶¨£¬ÓàϵĶàëÄÁ´£¨ÉÙÁËÒ»¸ö²Ð»ù£©±»»ØÊÕÔÙ½øÐÐÏÂÒ»ÂÖ½µ½âÑ­»·¡£
20£¬Í¬Ô´µ°°×ÖÊ£¨homologous protein£©:À´×Ô²»Í¬ÖÖÀàÉúÎïµÄÐòÁк͹¦ÄÜÀàËÆµÄµ°°×ÖÊ£¬ÀýÈçѪºìµ°°×¡£
µÚ¶þÕÂ
1£¬¹¹ÐΣ¨configuration):Óлú·Ö×ÓÖи÷¸öÔ­×ÓÌØÓеĹ̶¨µÄ¿Õ¼äÅÅÁС£ÕâÖÖÅÅÁв»¾­¹ý¹²¼Û¼üµÄ¶ÏÁѺÍÖØÐÂÐγÉÊDz»»á¸Ä±äµÄ¡£¹¹ÐεĸıäÍùÍùʹ·Ö×ӵĹâѧ»îÐÔ·¢Éú±ä»¯¡£
2£¬¹¹Ïó£¨conformation):Ö¸Ò»¸ö·Ö×ÓÖУ¬²»¸Ä±ä¹²¼Û¼ü½á¹¹£¬½öµ¥¼üÖÜΧµÄÔ­×Ó·ÅÖÃËù²úÉúµÄ¿Õ¼äÅŲ¼¡£Ò»ÖÖ¹¹Ïó¸Ä±äΪÁíÒ»ÖÖ¹¹Ïóʱ£¬²»ÒªÇó¹²¼Û¼üµÄ¶ÏÁѺÍÖØÐÂÐγɡ£¹¹Ïó¸Ä±ä²»»á¸Ä±ä·Ö×ӵĹâѧ»îÐÔ¡£
3£¬ëĵ¥Î»£¨peptide unit£©:ÓÖ³ÆÎªëÄ»ù£¨peptide group£©£¬ÊÇëļüÖ÷Á´ÉϵÄÖØ¸´½á¹¹¡£ÊÇÓɲÎÓÚëÄÁ´ÐγɵĵªÔ­×Ó£¬Ì¼Ô­×ÓºÍËüÃǵÄ4¸öÈ¡´ú³É·Ö:ôÊ»ùÑõÔ­×Ó£¬õ£°±ÇâÔ­×ÓºÍÁ½¸öÏàÁÚ¦Á-̼ԭ×Ó×é³ÉµÄÒ»¸öÆ½Ãæµ¥Î»¡£
4£¬µ°°×Öʶþ¼¶½á¹¹£¨proteinÔÚµ°°×ÖÊ·Ö×ÓÖеľֲ¼ÇøÓòÄÚ°±»ùËá²Ð»ùµÄÓйæÔòµÄÅÅÁС£³£¼ûµÄÓжþ¼¶½á¹¹ÓЦÁ-ÂÝÐýºÍ¦Â-ÕÛµþ¡£¶þ¼¶½á¹¹ÊÇͨ¹ý¹Ç¼ÜÉϵÄôÊ»ùºÍõ£°·»ùÍÅÖ®¼äÐγɵÄÇâ¼üά³ÖµÄ¡£
5£¬µ°°×ÖÊÈý¼¶½á¹¹£¨protein tertiary structure£©: µ°°×ÖÊ·Ö×Ó´¦ÓÚËüµÄÌìÈ»ÕÛµþ״̬µÄÈýά¹¹Ïó¡£Èý¼¶½á¹¹ÊÇÔÚ¶þ¼¶½á¹¹µÄ»ù´¡ÉϽøÒ»²½ÅÌÈÆ£¬ÕÛµþÐγɵġ£Èý¼¶½á¹¹Ö÷ÒªÊÇ¿¿°±»ùËá²àÁ´Ö®¼äµÄÊèË®Ï໥×÷Óã¬Çâ¼ü£¬·¶µÂ»ªÁ¦ºÍÑμüά³ÖµÄ¡£
6£¬µ°°×ÖÊËļ¶½á¹¹£¨protein quaternary structure£©:¶àÑÇ»ùµ°°×ÖʵÄÈýά½á¹¹¡£Êµ¼ÊÉÏÊǾßÓÐÈý¼¶½á¹¹¶àëÄ£¨ÑÇ»ù£©ÒÔÊʵ±·½Ê½¾ÛºÏËù³ÊÏÖµÄÈýά½á¹¹¡£
7£¬¦Á-ÂÝÐý£¨¦Á-heliv£©:µ°°×ÖÊÖг£¼ûµÄ¶þ¼¶½á¹¹£¬ëÄÁ´Ö÷Á´ÈƼÙÏëµÄÖÐÐÄÖáÅÌÈÆ³ÉÂÝÐý×´£¬Ò»°ã¶¼ÊÇÓÒÊÖÂÝÐý½á¹¹£¬ÂÝÐýÊÇ¿¿Á´ÄÚÇâ¼üά³ÖµÄ¡£Ã¿¸ö°±»ùËá²Ð»ù£¨µÚn¸ö£©µÄôÊ»ùÓë¶àëÄÁ´C¶Ë·½ÏòµÄµÚ4¸ö²Ð»ù£¨µÚ4+n¸ö£©µÄõ£°·µªÐγÉÇâ¼ü¡£ÔڹŵäµÄÓÒÊÖ¦Á-ÂÝÐý½á¹¹ÖУ¬ÂݾàΪ0.54nm£¬Ã¿Ò»È¦º¬ÓÐ3.6¸ö°±»ùËá²Ð»ù£¬Ã¿¸ö²Ð»ùÑØ×ÅÂÝÐýµÄ³¤ÖáÉÏÉý0.15nm.
8, ¦Â-ÕÛµþ£¨¦Â-sheet£©: µ°°×ÖÊÖг£¼ûµÄ¶þ¼¶½á¹¹,ÊÇÓÉÉìÕ¹µÄ¶àëÄÁ´×é³ÉµÄ¡£ÕÛµþƬµÄ¹¹ÏóÊÇͨ¹ýÒ»¸öëļüµÄôÊ»ùÑõºÍλÓÚͬһ¸öëÄÁ´µÄÁíÒ»¸öõ£°±ÇâÖ®¼äÐγɵÄÇâ¼üά³ÖµÄ¡£Çâ¼ü¼¸ºõ¶¼´¹Ö±ÉìÕ¹µÄëÄÁ´£¬ÕâЩëÄÁ´¿ÉÒÔÊÇÆ½ÐÐÅÅÁУ¨ÓÉNµ½C·½Ïò£©»òÕßÊÇ·´Æ½ÐÐÅÅÁУ¨ëÄÁ´·´ÏòÅÅÁУ©¡£
9£¬¦Â-ת½Ç£¨¦Â-turn£©:Ò²ÊǶàëÄÁ´Öг£¼ûµÄ¶þ¼¶½á¹¹,ÊÇÁ¬½Óµ°°×ÖÊ·Ö×ÓÖеĶþ¼¶½á¹¹£¨¦Á-ÂÝÐýºÍ¦Â-ÕÛµþ£©£¬Ê¹ëÄÁ´×ßÏò¸Ä±äµÄÒ»ÖÖ·ÇÖØ¸´¶àëÄÇø£¬Ò»°ãº¬ÓÐ2¡«16¸ö°±»ùËá²Ð»ù¡£º¬ÓÐ5¸öÒÔÉϵݱ»ùËá²Ð»ùµÄת½ÇÓÖ³£³ÆÎª»·£¨loop£©¡£³£¼ûµÄת½Çº¬ÓÐ4¸ö°±»ùËá²Ð»ùÓÐÁ½ÖÖÀàÐÍ:ת½ÇIµÄÌØµãÊÇ:µÚÒ»¸ö°±»ùËá²Ð»ùôÊ»ùÑõÓëµÚËĸö²Ð»ùµÄõ£°±µªÖ®¼äÐγÉÇâ¼ü£»×ª½Ç¢òµÄµÚÈý¸ö²Ð»ùÍùÍùÊǸʰ±Ëá¡£ÕâÁ½ÖÖת½ÇÖеĵڶþ¸ö²ÐÙ¨´ó¶¼ÊǸ¬°±Ëá¡£
10£¬³¬¶þ¼¶½á¹¹£¨super-secondary structure£©:Ò²³ÆÎª»ùÔª(motif).ÔÚµ°°×ÖÊÖУ¬ÌرðÊÇÇòµ°°×ÖУ¬¾­³£¿ÉÒÔ¿´µ½ÓÉÈô¸ÉÏàÁڵĶþ¼¶½á¹¹µ¥Ôª×éºÏÔÚÒ»Æð£¬±Ë´ËÏ໥×÷Óã¬ÐγÉÓйæÔòµÄ£¬ÔÚ¿Õ¼äÉÏÄܱæÈϵĶþ¼¶½á¹¹×éºÏÌå¡£
11£¬½á¹¹Óò£¨domain£©:ÔÚµ°°×ÖʵÄÈý¼¶½á¹¹ÄڵĶÀÁ¢ÕÛµþµ¥Ôª¡£½á¹¹Óòͨ³£¶¼ÊǼ¸¸ö³¬¶þ¼¶½á¹¹µ¥ÔªµÄ×éºÏ¡£
12£¬ÏËάµ°°×£¨fibrous protein£©:Ò»ÀàÖ÷ÒªµÄ²»ÈÜÓÚË®µÄµ°°×ÖÊ£¬Í¨³£¶¼º¬ÓгÊÏÖÏàͬ¶þ¼¶½á¹¹µÄ¶àëÄÁ´Ðí¶àÏËάµ°°×½áºÏ½ôÃÜ£¬²¢Îª µ¥¸öϸ°û»òÕû¸öÉúÎïÌåÌṩ»úеǿ¶È£¬Æð×ű£»¤»ò½á¹¹ÉϵÄ×÷Óá£
13£¬Çòµ°°×(globular protein):½ô´ÕµÄ£¬½üËÆÇòÐεģ¬º¬ÓÐÕÛµþ½ôÃܵĶàëÄÁ´µÄÒ»À൰°×ÖÊ£¬Ðí¶à¶¼ÈÜÓÚË®¡£µäÐεÄÇòµ°°×º¬ÓÐÄÜÌØÒìµÄʶ±ðÆäËü»¯ºÏÎïµÄ°¼ÏÝ»òÁÑ϶²¿Î»¡£
14,½Çµ°°×£¨keratin£©:ÓÉ´¦ÓÚ¦Á-ÂÝÐý»ò¦Â-ÕÛµþ¹¹ÏóµÄƽÐеĶàëÄÁ´×é³É²»ÈÜÓÚË®µÄÆð×ű£»¤»ò½á¹¹×÷Óõ°°×ÖÊ¡£
15,½ºÔ­£¨µ°°×£©£¨collagen£©:ÊǶ¯Îï½áµÞ×éÖ¯×î·á¸»µÄÒ»ÖÖµ°°×ÖÊ£¬ËüÊÇÓÉÔ­½ºÔ­µ°°×·Ö×Ó×é³É¡£Ô­½ºÔ­µ°°×ÊÇÒ»ÖÖ¾ßÓÐÓÒÊÖ³¬ÂÝÐý½á¹¹µÄµ°°×¡£Ã¿¸öÔ­½ºÔ­·Ö×Ó¶¼ÊÇÓÉ3ÌõÌØÊâµÄ×óÊÖÂÝÐý£¨Âݾà0.95nm,ÿһȦº¬ÓÐ3.3¸ö²Ð»ù£©µÄ¶àëÄÁ´ÓÒÊÖÐýתÐγɵġ£
16£¬ÊèË®Ï໥×÷ÓÃ(hydrophobic interaction):·Ç¼«ÐÔ·Ö×ÓÖ®¼äµÄÒ»ÖÖÈõµÄ·Ç¹²¼ÛµÄÏ໥×÷Óá£ÕâЩ·Ç¼«ÐԵķÖ×ÓÔÚË®Ïà»·¾³ÖоßÓбܿªË®¶øÏ໥¾Û¼¯µÄÇãÏò¡£
17£¬°éÄïµ°°×£¨chaperone£©:ÓëÒ»ÖÖкϳɵĶàëÄÁ´Ðγɸ´ºÏÎﲢЭÖúËüÕýÈ·ÕÛµþ³É¾ßÓÐÉúÎ﹦Äܹ¹ÏòµÄµ°°×ÖÊ¡£°éÄïµ°°×¿ÉÒÔ·ÀÖ¹²»ÕýÈ·ÕÛµþÖмäÌåµÄÐγɺÍûÓÐ×é×°µÄµ°°×ÑÇ»ùµÄ²»ÕýÈ·¾Û¼¯£¬Ð­Öú¶àëÄÁ´¿çĤתÔËÒÔ¼°´óµÄ¶àÑÇ»ùµ°°×ÖʵÄ×é×°ºÍ½âÌå¡£
18£¬¶þÁò¼ü£¨disulfide bond£©:ͨ¹ýÁ½¸ö£¨°ëë×°±ËᣩÛÏ»ùµÄÑõ»¯ÐγɵĹ²¼Û¼ü¡£¶þÁò¼üÔÚÎȶ¨Ä³Ð©µ°°×µÄÈýά½á¹¹ÉÏÆð×ÅÖØÒªµÄ×÷Óá£
19£¬·¶µÂ»ªÁ¦£¨van der Waals force£©:ÖÐÐÔÔ­×ÓÖ®¼äͨ¹ý˲¼ä¾²µçÏ໥×÷ÓòúÉúµÄÒ»ÈõµÄ·Ö×ÓÖ®¼äµÄÁ¦¡£µ±Á½¸öÔ­×ÓÖ®¼äµÄ¾àÀëΪËüÃÇ·¶µÂ»ªÁ¦°ë¾¶Ö®ºÍʱ£¬·¶µÂ»ªÁ¦×îÇ¿¡£Ç¿µÄ·¶µÂ»ªÁ¦µÄÅųâ×÷ÓÿɷÀÖ¹Ô­×ÓÏ໥¿¿½ü¡£
20£¬µ°°×ÖʱäÐÔ£¨denaturation£©:ÉúÎï´ó·Ö×ÓµÄÌìÈ»¹¹ÏóÔâµ½ÆÆ»µµ¼ÖÂÆäÉúÎï»îÐÔɥʧµÄÏÖÏó¡£µ°°×ÖÊÔÚÊܵ½¹âÕÕ£¬ÈÈ£¬ÓлúÈܼÃÒÔ¼°Ò»Ð©±äÐԼõÄ×÷ÓÃʱ£¬´Î¼¶¼üÊܵ½ÆÆ»µ£¬µ¼ÖÂÌìÈ»¹¹ÏóµÄÆÆ»µ£¬Ê¹µ°°×ÖʵÄÉúÎï»îÐÔɥʧ¡£
21£¬¼¡ºìµ°°×£¨myoglobin£©:ÊÇÓÉÒ»ÌõëÄÁ´ºÍÒ»¸öѪºìËØ¸¨»ù×é³ÉµÄ½áºÏµ°°×£¬ÊǼ¡ÈâÄÚ´¢´æÑõµÄµ°°×ÖÊ£¬ËüµÄÑõ±¥ºÍÇúÏßΪ˫ÇúÏßÐÍ¡£
22£¬¸´ÐÔ£¨renaturation£©:ÔÚÒ»¶¨µÄÌõ¼þÏ£¬±äÐÔµÄÉúÎï´ó·Ö×Ó»Ö¸´³É¾ßÓÐÉúÎï»îÐÔµÄÌìÈ»¹¹ÏóµÄÏÖÏó¡£
23£¬²¨¶ûЧӦ£¨Bohr effect£©:CO2Ũ¶ÈµÄÔö¼Ó½µµÍϸ°ûÄÚµÄpH£¬ÒýÆðºìϸ°ûÄÚѪºìµ°°×ÑõÇ׺ÍÁ¦Ï½µµÄÏÖÏó¡£
24£¬Ñªºìµ°°×£¨hemoglobin£©: ÊÇÓɺ¬ÓÐѪºìËØ¸¨»ùµÄ4¸öÑÇ»ù×é³ÉµÄ½áºÏµ°°×¡£Ñªºìµ°°×¸ºÔð½«ÑõÓÉ·ÎÔËÊäµ½ÍâÖÜ×éÖ¯£¬ËüµÄÑõ±¥ºÍÇúÏßΪSÐÍ¡£
25,±ð¹¹Ð§Ó¦£¨allosteric effect£©:ÓÖ³ÆÎª±ä¹¹Ð§Ó¦£¬ÊǹѾ۵°°×ÓëÅä»ù½áºÏ¸Ä±äµ°°×ÖʵĹ¹Ï󣬵¼Öµ°°×ÖÊÉúÎï»îÐÔɥʧµÄÏÖÏó¡£
26£¬Á­µ¶ÐÍϸ°ûƶѪ²¡£¨sickle-cell anemia£©: Ѫºìµ°°×·Ö×ÓÒÅ´«È±ÏÝÔì³ÉµÄÒ»ÖÖ¼²²¡£¬²¡È˵Ĵ󲿷ֺìϸ°û³ÊÁ­µ¶×´¡£ÆäÌØµãÊDz¡È˵ÄѪºìµ°°×¦Â-ÑÇ»ùN¶ËµÄµÚÁù¸ö°±»ùËá²ÐȱÊÇçÓ°±Ëᣨvol£©£¬¶ø²»ÊÇÏÂÕý³£µÄ¹È°±Ëá²Ð»ù(Ghe)¡£
µÚÈýÕÂ
1£¬Ã¸£¨enzyme£©:ÉúÎï´ß»¯¼Á£¬³ýÉÙÊýRNAÍ⼸ºõ¶¼Êǵ°°×ÖÊ¡£Ã¸²»¸Ä±ä·´Ó¦µÄƽºâ£¬Ö»ÊÇ
ͨ¹ý½µµÍ»î»¯Äܼӿ췴ӦµÄËÙ¶È¡£
2,ÍѸ¬»ùøµ°°×(apoenzyme):øÖгýÈ¥´ß»¯»îÐÔ¿ÉÄÜÐèÒªµÄÓлú»òÎÞ»ú¸¨ÖúÒò×Ó»ò¸¨»ùºóµÄµ°°×Öʲ¿·Ö¡£
3£¬È«Ã¸£¨holoenzyme£©:¾ßÓд߻¯»îÐÔµÄø£¬°üÀ¨ËùÓбØÐèµÄÑÇ»ù£¬¸¨»ùºÍÆäËü¸¨ÖúÒò×Ó¡£
4£¬Ã¸»îÁ¦µ¥Î»£¨U,active unit£©:ø»îÁ¦µ¥Î»µÄÁ¿¶È¡£1961Äê¹ú¼Êøѧ»áÒ鹿¶¨:1¸öø»îÁ¦µ¥Î»ÊÇÖ¸ÔÚÌØ¶¨Ìõ¼þ£¨25ºC£¬ÆäËüΪ×îÊÊÌõ¼þ£©Ï£¬ÔÚ1minÄÚÄÜת»¯1¦Ìmolµ×ÎïµÄøÁ¿£¬»òÊÇת»¯µ×ÎïÖÐ1¦ÌmolµÄÓйػùÍŵÄøÁ¿¡£
5£¬±È»î£¨specific activity£©:ÿ·ÖÖÓÿºÁ¿Ëøµ°°×ÔÚ25ºCÏÂת»¯µÄµ×ÎïµÄ΢Ħ¶ûÊý¡£±È»îÊÇø´¿¶ÈµÄ²âÁ¿¡£
6£¬»î»¯ÄÜ£¨activation energy£©:½«1mol·´Ó¦µ×ÎïÖÐËùÓзÖ×ÓÓÉÆä̬ת»¯Îª¹ý¶È̬ËùÐèÒªµÄÄÜÁ¿¡£
7£¬»îÐÔ²¿Î»£¨active energy£©:øÖк¬Óе×Îï½áºÏ²¿Î»ºÍ²ÎÓë´ß»¯µ×Îïת»¯Îª²úÎïµÄ°±»ùËá²Ð»ù²¿·Ö¡£»îÐÔ²¿Î»Í¨³£Î»ÓÚµ°°×ÖʵĽṹÓò»òÑÇ»ùÖ®¼äµÄÁÑ϶»òÊǵ°°×ÖʱíÃæµÄ°¼Ïݲ¿Î»£¬Í¨³£¶¼ÊÇÓÉÔÚÈýά¿Õ¼äÉÏ¿¿µÃºÜ½øµÄһЩ°±»ùËá²Ð»ù×é³É¡£
8£¬Ëá-¼î´ß»¯£¨acid-base catalysis£©:ÖÊ×Ó×ªÒÆ¼ÓËÙ·´Ó¦µÄ´ß»¯×÷Óá£
9£¬¹²¼Û´ß»¯£¨covalent catalysis£©:Ò»¸öµ×Îï»òµ×ÎïµÄÒ»²¿·ÖÓë´ß»¯¼ÁÐγɹ²¼Û¼ü£¬È»ºó±»×ªÒƸøµÚ¶þ¸öµ×Îï¡£Ðí¶àø´ß»¯µÄ»ùÍÅ×ªÒÆ·´Ó¦¶¼ÊÇͨ¹ý¹²¼Û·½Ê½½øÐеġ£
10£¬¿¿½üЧӦ£¨proximity effect£©:·Çø´Ù´ß»¯·´Ó¦»òø´Ù·´Ó¦ËٶȵÄÔö¼ÓÊÇÓÉÓÚµ×Îï¿¿½ü»îÐÔ²¿Î»£¬Ê¹µÃ»îÐÔ²¿Î»´¦·´Ó¦¼ÁÓÐЧŨ¶ÈÔö´óµÄ½á¹û£¬Õ⽫µ¼Ö¸üƵ·±µØÐγɹý¶È̬¡£
11£¬³õËÙ¶È(initial velocity):ø´Ù·´Ó¦×î³õ½×¶Îµ×Îïת»¯Îª²úÎïµÄËÙ¶È£¬ÕâÒ»½×¶Î²úÎïµÄŨ¶È·Ç³£µÍ£¬ÆäÄæ·´Ó¦¿ÉÒÔºöÂÔ²»¼Æ¡£
12£¬Ã×ÊÏ·½³Ì£¨Michaelis-Mentent equation£©:±íʾһ¸öø´Ù·´Ó¦µÄÆðʼËÙ¶È£¨¦Ô£©Óëµ×ÎïŨ¶È([s])¹ØÏµµÄËÙ¶È·½³Ì:¦Ô=¦Ômax[s]/(Km+[s])
13£¬Ã×Êϳ£Êý£¨Michaelis constant£©:¶ÔÓÚÒ»¸ö¸ø¶¨µÄ·´Ó¦£¬ÒìÖÁø´Ù·´Ó¦µÄÆðʼËÙ¶È£¨¦Ô0£©´ïµ½×î´ó·´Ó¦ËÙ¶È£¨¦Ômax£©Ò»°ëʱµÄµ×ÎïŨ¶È¡£
14£¬´ß»¯³£Êý£¨catalytic number£©(Kcat):Ò²³ÆÎª×ª»»Êý¡£ÊÇÒ»¸ö¶¯Á¦Ñ§³£Êý£¬ÊÇÔÚµ×Îï´¦ÓÚ±¥ºÍ״̬ÏÂÒ»¸öø£¨»òÒ»¸öø»îÐÔ²¿Î»£©´ß»¯Ò»¸ö·´Ó¦Óжà¿ìµÄ²âÁ¿¡£´ß»¯³£ÊýµÈÓÚ×î´ó·´Ó¦ËٶȳýÒÔ×ܵÄøŨ¶È£¨¦Ômax/[E]total£©¡£»òÊÇÿĦø»îÐÔ²¿Î»Ã¿ÃëÖÓת»¯Îª²úÎïµÄµ×ÎïµÄÁ¿£¨Ä¦[¶û]£©¡£
15£¬Ë«µ¹Êý×÷ͼ£¨double-reciprocal plot£©:ÄdzÆÎªLineweaver_Burk×÷ͼ¡£Ò»¸öø´Ù·´Ó¦µÄËٶȵĵ¹Êý£¨1/V£©¶Ôµ×Îï¶ÈµÄµ¹Êý£¨1/LSF£©µÄ×÷ͼ¡£xºÍyÖáÉϵĽؾà·Ö±ð´ú±íÃ×Êϳ£ÊýºÍ×î´ó·´Ó¦Ëٶȵĵ¹Êý¡£
16£¬¾ºÕùÐÔÒÖÖÆ×÷Óã¨competitive inhibition£©:ͨ¹ýÔö¼Óµ×ÎïŨ¶È¿ÉÒÔÄæ×ªµÄÒ»ÖÖøÒÖÖÆÀàÐÍ¡£¾ºÕùÐÔÒÖÖÆ¼Áͨ³£ÓëÕý³£µÄµ×Îï»òÅäÌ徺Õùͬһ¸öµ°°×ÖʵĽáºÏ²¿Î»¡£ÕâÖÖÒÖÖÆÊ¹KmÔö´ó¶ø
¦Ômax²»±ä¡£
17£¬·Ç¾ºÕùÐÔÒÖÖÆ×÷Óã¨noncompetitive inhibition£©: ÒÖÖÆ¼Á²»½öÓëÓÎÀëø½áºÏ£¬Ò²¿ÉÒÔÓëø-µ×Î︴ºÏÎï½áºÏµÄÒ»ÖÖø´Ù·´Ó¦ÒÖÖÆ×÷Óá£ÕâÖÖÒÖÖÆÊ¹Km²»±ä¶ø¦Ômax±äС¡£
18£¬·´¾ºÕùÐÔÒÖÖÆ×÷Óã¨uncompetitive inhibition£©: ÒÖÖÆ¼ÁÖ»Óëø-µ×Î︴ºÏÎï½áºÏ¶ø²»ÓëÓÎÀëµÄø½áºÏµÄÒ»ÖÖø´Ù·´Ó¦ÒÖÖÆ×÷Óá£ÕâÖÖÒÖÖÆÊ¹KmºÍ¦Ômax¶¼±äСµ«¦Ômax/Km²»±ä¡£
19£¬Ë¿°±Ëáµ°°×ø£¨serine protease£©: »îÐÔ²¿Î»º¬ÓÐÔÚ´ß»¯ÆÚ¼äÆðÇ׺Ë×÷ÓõÄË¿°±²Ð»ùµÄµ°°×ÖÊ¡£
20£¬Ã¸Ô­£¨zymogen£©:ͨ¹ýÓÐÏÞµ°°×Ë®½â£¬Äܹ»ÓÉÎÞ»îÐÔ±ä³É¾ßÓд߻¯»îÐÔµÄøǰÌå¡£
21£¬µ÷½Úø£¨regulatory enzyme£©:λÓÚÒ»¸ö»ò¶à¸ö´úл;¾¶ÄÚµÄÒ»¸ö¹Ø¼ü²¿Î»µÄø£¬ËüµÄ»îÐÔ¸ù¾Ý´úлµÄÐèÒª¶øÔö¼Ó»ò½µµÍ¡£
22£¬±ð¹¹Ã¸£¨allosteric enzyme£©:»îÐÔÊܽáºÏÔÚ»îÐÔ²¿Î»ÒÔÍâµÄ²¿Î»µÄÆäËü·Ö×Óµ÷½ÚµÄø¡£
23£¬±ð¹¹µ÷½Ú¼Á£¨allosteric modulator£©:½áºÏÔڱ𹹵÷½ÚøµÄµ÷½Ú²¿Î»µ÷½Ú¸Ãø´ß»¯»îÐÔµÄÉúÎï·Ö×Ó£¬±ð¹¹µ÷½Ú¼Á¿ÉÒÔÊǼ¤»î¼Á£¬Ò²¿ÉÒÔÊÇÒÖÖÆ¼Á¡£
24£¬Æë±äģʽ£¨concerted model£©:ÏàͬÅäÌåÓë¹Ñ¾Ûµ°°×Эͬ½áºÏµÄÒ»ÖÖģʽ£¬°´ÕÕ×î¼òµ¥µÄÆë±äģʽ£¬ÓÉÓÚÒ»¸öµ×Îï»ò±ð¹¹µ÷½Ú¼ÁµÄ½áºÏ£¬µ°°×ÖʵĹ¹ÏàÔÚT£¨¶Ôµ×ÎïÇ׺ÍÐԵ͵Ĺ¹Ï󣩺ÍR£¨¶Ôµ×ÎïÇ׺ÍÐԸߵĹ¹Ïó£©Ö®¼ä±ä»»¡£ÕâһģʽÌá³öËùÓе°°×ÖʵÄÑÇ»ù¶¼¾ßÓÐÏàͬµÄ¹¹Ï󣬻òÊÇT¹¹Ï󣬻òÊÇR¹¹Ïó¡£
25£¬Ðò±äģʽ£¨sequential model£©:ÏàͬÅäÌåÓë¹Ñ¾Ûµ°°×Эͬ½áºÏµÄÁíÍâÒ»ÖÖģʽ¡£°´ÕÕ×î¼òµ¥µÄÐò±äģʽ£¬Ò»¸öÅäÌåµÄ½áºÏ»áÓÕµ¼Ëü½áºÏµÄÑÇ»ùµÄÈý¼¶½á¹¹µÄ±ä»¯£¬²¢Ê¹ÏàÁÚÑÇ»ùµÄ¹¹Ïó·¢ÉúºÜ´óµÄ±ä»¯¡£°´ÕÕÐò±äģʽ£¬Ö»ÓÐÒ»¸öÑÇ»ù¶ÔÅäÌå¾ßÓиߵÄÇ׺ÍÁ¦¡£
26£¬Í¬¹¦Ã¸£¨isoenzyme isozyme£©:´ß»¯Í¬Ò»»¯Ñ§·´Ó¦¶ø»¯Ñ§×é³É²»Í¬µÄÒ»×éø¡£ËüÃDZ˴ËÔÚ°±»ùËáÐòÁУ¬µ×ÎïµÄÇ׺ÍÐԵȷ½Ãæ¶¼´æÔÚ×ŲîÒì¡£
27£¬±ð¹¹µ÷½Úø£¨allosteric modulator£©:ÄdzÆÎª±ð¹¹Ð§Ó¦Îï¡£½áºÏÔÚ±ð¹¹Ã¸µÄµ÷½Ú²¿Î»£¬µ÷½Úø´ß»¯»îÐÔµÄÉúÎï·Ö×Ó¡£±ð¹¹µ÷½ÚÎï¿ÉÒÔÊÇÊǼ¤»î¼Á£¬Ò²¿ÉÒÔÊÇÒÖÖÆ¼Á¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jdklgjldg

ľ³æ (ÕýʽдÊÖ)

1

ºÜºÃµÄ
ÎÒµÄÄ¿±ê:ŵ±´¶ûҽѧÓëÉúÀíѧ½±
2Â¥2006-04-13 10:44:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

0.5

3Â¥2006-04-13 16:57:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1

4Â¥2006-04-24 15:14:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ mengzhongmeng µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á +7 ÎÒ²»ÊÇÖ»Òò 2026-04-02 8/400 2026-04-03 00:15 by ÓêÌì³ÅÉ¡
[¿¼ÑÐ] 302Çóµ÷¼Á +9 zyxÉϰ¶£¡ 2026-04-02 9/450 2026-04-02 23:07 by Âí¶ù¿ì¿ìµØÅÜ
[¿¼ÑÐ] 312 »¯¹¤»òÖÆÒ©µ÷¼Á +7 ССī123 2026-04-02 8/400 2026-04-02 22:15 by ZXlzxl0425
[¿¼ÑÐ] 0703»¯Ñ§ +5 goldtt 2026-04-02 7/350 2026-04-02 21:32 by dongzh2009
[¿¼ÑÐ] ²ÄÁÏ340·Öµ÷¼Á +7 ÏÄÒ¹Íí·ç_long 2026-04-02 9/450 2026-04-02 21:20 by dongzh2009
[¿¼ÑÐ] 070305¸ß·Ö×Ó»¯Ñ§ÓëÎïÀí 304·ÖÇóµ÷¼Á +16 c297914 2026-03-28 16/800 2026-04-02 20:50 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼ÁÇóµ÷¼Á +7 121. 2026-04-02 7/350 2026-04-02 19:15 by dick_runner
[ÂÛÎÄͶ¸å] chinese chemical lettersÓ¢ÎİæÍ¶¸åÇóÖú 120+4 Yishengeryi 2026-03-30 6/300 2026-04-02 17:19 by Yishengeryi
[¿¼ÑÐ] 348Çóµ÷¼Á +11 zzzzyk123 2026-04-01 11/550 2026-04-02 16:52 by Wang200018
[¿¼ÑÐ] 275ѧ˶081000·þ´Óµ÷¼Áµ½ÆäËûרҵ£¬±£²»×¡±¾×¨ÒµÁË +7 һֻССˮţ 2026-04-02 8/400 2026-04-02 14:23 by alice-2022
[¿¼ÑÐ] 372Çóµ÷¼Á +3 jjÓ¿77 2026-04-02 3/150 2026-04-02 09:57 by olim
[¿¼ÑÐ] 295²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +19 1428151015 2026-03-27 19/950 2026-04-01 22:34 by peike
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»²ÄÁϹ¤³Ì×Ü·Ö358 +5 cs0106 2026-04-01 7/350 2026-04-01 11:45 by wangjy2002
[¿¼ÑÐ] 318Çóµ÷¼Á +8 ÆßÒä77 2026-04-01 8/400 2026-04-01 10:37 by Jaylen.
[¿¼ÑÐ] 0856²ÄÁÏ»¯¹¤µ÷¼Á ×Ü·Ö330 +18 zhubinhao 2026-03-27 18/900 2026-04-01 09:37 by oooqiao
[¿¼ÑÐ] ¿¼ÑÐÉúÎïÓëÒ½Ò©µ÷¼Á +7 Ìúº©º©123425 2026-03-31 7/350 2026-04-01 08:45 by JourneyLucky
[¿¼ÑÐ] 335Çóµ÷¼Á +3 321* 2026-03-31 4/200 2026-04-01 00:00 by 321*
[¿¼ÑÐ] ºÏ·ÊÇøÓòÐÔÖØµãÒ»±¾ÕÐÊÕµ÷¼Á +4 6266jl 2026-03-30 8/400 2026-03-31 18:43 by 6266jl
[¿¼ÑÐ] Çóµ÷¼Á +10 ¼Ò¼Ñ¼Ñ¼Ñ¼Ñ¼Ñ 2026-03-29 10/500 2026-03-30 18:34 by 544594351
[¿¼ÑÐ] 081200-314 +3 LILIQQ 2026-03-27 4/200 2026-03-28 09:41 by ±£»¤µØÇòÄãÎÒ×öÆ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û